Connection

Mark Kindy to Brain Injuries

This is a "connection" page, showing publications Mark Kindy has written about Brain Injuries.
Connection Strength

0.967
  1. The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury. J Neurotrauma. 2014 Mar 01; 31(5):515-29.
    View in: PubMed
    Score: 0.348
  2. Protective effects of incensole acetate on cerebral ischemic injury. Brain Res. 2012 Mar 14; 1443:89-97.
    View in: PubMed
    Score: 0.301
  3. SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY. J Biol Chem. 2016 Jan 22; 291(4):1957-1973.
    View in: PubMed
    Score: 0.099
  4. Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury. J Biol Chem. 2014 May 09; 289(19):13142-54.
    View in: PubMed
    Score: 0.088
  5. Decompressive craniectomy: technical note. Acta Neurol Scand. 2011 Apr; 123(4):239-44.
    View in: PubMed
    Score: 0.071
  6. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A. 2001 Feb 13; 98(4):1952-7.
    View in: PubMed
    Score: 0.035
  7. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med. 1996 Jul; 2(7):788-94.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.